Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel told the Financial Times. “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to … are like ‘this is not going to be good.'” Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified. He further told the Financial Times that he believes it could be months before pharmaceutical companies can manufacture vaccines …